help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pappolla, M. A.
Right arrow Articles by Bozner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pappolla, M. A.
Right arrow Articles by Bozner, P.

American Journal of Pathology, Vol 152, 871-877, Copyright © 1998 by American Society for Investigative Pathology


REGULAR ARTICLES

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo

MA Pappolla, YJ Chyan, RA Omar, K Hsiao, G Perry, MA Smith and P Bozner
University of South Alabama, Mobile 36617, USA. mpappoll@usamail.usouthal.edu

Increased expression of antioxidant enzymes and heat-shock proteins are key markers of oxidative stress. Such proteins are abnormally present within the neuropathological lesions of Alzheimer's disease (AD), suggesting that oxidative stress may play significant but yet undefined roles in this disorder. To gain further insight into the role of oxidative stress in AD, we studied the expression of CuZn superoxide dismutase (SOD) and hemoxygenase-1 (HO-1), two established markers of oxidative stress, in a transgenic mouse model of AD. Immunohistochemistry with anti-SOD and anti-HO-1 antibodies revealed a very pronounced increase of these proteins only in aged transgene- positive mice. Interestingly, the distribution of the oxidative burden was largely overlapping with dystrophic neuritic elements in the mice as highlighted with anti-ubiquitin antibodies. Because the most conspicuous alterations were identified around amyloid (Abeta) deposits, our results provide strong support for the hypothesis that Abeta is neurotoxic in vivo and that such toxicity is mediated by free radicals. To obtain additional experimental evidence for such an interpretation (ie, a cause-effect relationship between Abeta and oxidative neurotoxicity), PC12 cells were exposed to increasing concentrations of Abeta or to oxidative stress. In agreement with the in vivo findings, either treatment caused marked induction of SOD or HO- 1 in a dose-dependent fashion. These results validate the transgenic approach for the study of oxidative stress in AD and for the evaluation of antioxidant therapies in vivo.


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
H. J. KIM, K. W. LEE, and H. J. LEE
Protective Effects of Piceatannol against Beta-Amyloid-Induced Neuronal Cell Death
Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Manczak, T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy
Mitochondria are a direct site of A{beta} accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
Hum. Mol. Genet., May 1, 2006; 15(9): 1437 - 1449.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
R. J. Castellani, H.-g. Lee, G. Perry, and M. A. Smith
Antioxidant protection and neurodegenerative disease: The role of amyloid-{beta} and tau
American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 126 - 130.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
B. Kumar, P. Nahreini, A. J. Hanson, C. Andreatta, J. E. Prasad, and K. N. Prasad
Selenomethionine Prevents Degeneration Induced by Overexpression of Wild-Type Human {alpha}-Synuclein during Differentiation of Neuroblastoma Cells
J. Am. Coll. Nutr., December 1, 2005; 24(6): 516 - 523.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. M. LoPachin and A. P. DeCaprio
Protein Adduct Formation as a Molecular Mechanism in Neurotoxicity
Toxicol. Sci., August 1, 2005; 86(2): 214 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. E. McLellan, S. T. Kajdasz, B. T. Hyman, and B. J. Bacskai
In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy
J. Neurosci., March 15, 2003; 23(6): 2212 - 2217.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. N. Prasad, W. C. Cole, and K. C. Prasad
Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment
J. Am. Coll. Nutr., December 1, 2002; 21(6): 506 - 522.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
K. A. Corcoran, Y. Lu, R. S. Turner, and S. Maren
Overexpression of hAPPswe Impairs Rewarded Alternation and Contextual Fear Conditioning in a Transgenic Mouse Model of Alzheimer's Disease
Learn. Mem., September 1, 2002; 9(5): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Q. Trojanowski
Neuropathological Verisimilitude in Animal Models of Alzheimer's Disease : Key to Elucidating Neurodegenerative Pathways and Identifying New Targets for Drug Discovery
Am. J. Pathol., February 1, 2002; 160(2): 409 - 411.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-T. Gau, M. L. Steinhilb, T.-C. Kao, C. J. D'Amato, J. R. Gaut, K. A. Frey, and R. S. Turner
Stable {beta}-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice
Am. J. Pathol., February 1, 2002; 160(2): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
J. Neurosci., November 1, 2001; 21(21): 8370 - 8377.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Pratico, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee
Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis
J. Neurosci., June 15, 2001; 21(12): 4183 - 4187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. S. Turner
Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk
Am. J. Pathol., March 1, 2001; 158(3): 797 - 801.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. H. ASHE
Synaptic Structure and Function in Transgenic APP Mice
Ann. N.Y. Acad. Sci., December 1, 2000; 924(1): 39 - 41.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. D. Yan, A. Roher, A. M. Schmidt, and D. M. Stern
Cellular Cofactors for Amyloid {beta}-Peptide-Induced Cell Stress : Moving from Cell Culture to in Vivo
Am. J. Pathol., November 1, 1999; 155(5): 1403 - 1411.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-J. Chyan, B. Poeggeler, R. A. Omar, D. G. Chain, B. Frangione, J. Ghiso, and M. A. Pappolla
Potent Neuroprotective Properties against the Alzheimer beta -Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid
J. Biol. Chem., July 30, 1999; 274(31): 21937 - 21942.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Love, R. Barber, and G. K. Wilcock
Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease
Brain, February 1, 1999; 122(2): 247 - 253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.